What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses
Vale, C Rydzewska, L Tierney, J Albiges, L Clarke, Noel W Fisher, D Fizazi, K James, N Mason, M Parmar, M
Vale, C
Rydzewska, L
Tierney, J
Albiges, L
Clarke, Noel W
Fisher, D
Fizazi, K
James, N
Mason, M
Parmar, M
Citations
Altmetric:
Abstract
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses. 2015, 51 S719-S720 Eur J Cancer